Toluene

Toluene

SCHEMBL1931900

Cc1ccccc1.O=P(O)(O)O.[KH]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Toluene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.61
TSHR P16473 2/20 0.61
ALOX12 P18054 1/20 0.61
ACHE P22303 1/20 0.61
ACP3 P15309 2/20 0.48
CA2 P00918 1/20 0.48
CA4 P22748 1/20 0.48
CA5A P35218 1/20 0.48
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MAPT P10636 1/20 0.43
SRC P12931 2/20 0.42
CFTR P13569 1/20 0.42
POLB P06746 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PTPN1 P18031 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Toluene SCHEMBL27955550 1.00 LMNA (0.61) LMNATSHRALOX12ACHEACP3
Toluene SCHEMBL27988775 0.97 LMNA (0.58) LMNATSHRALOX12ACHEACP3
Toluene SCHEMBL695755 0.97 LMNA (0.65) LMNATSHRALOX12ACHEACP3
Toluene SCHEMBL28555681 0.97 LMNA (0.65) LMNATSHRALOX12ACHEACP3
Toluene SCHEMBL5806354 0.97 LMNA (0.65) LMNATSHRALOX12ACHEACP3
Toluene SCHEMBL437383 0.97 LMNA (0.65) LMNATSHRALOX12ACHEACP3
Toluene SCHEMBL1011089 0.97 LMNA (0.65) LMNATSHRALOX12ACHEACP3
Toluene SCHEMBL10856877 0.97 LMNA (0.65) LMNATSHRALOX12ACHEACP3
Toluene SCHEMBL27269290 0.97 LMNA (0.65) LMNATSHRALOX12ACHEACP3
Toluene SCHEMBL3630619 0.94 LMNA (0.61) LMNATSHRALOX12ACHEACP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12215275-B2 Compositions for enhanced oil recovery CHAMPIONX LLC 2025-02-04 US claimed
US-20220298408-A1 COMPOSITIONS FOR ENHANCED OIL RECOVERY CHAMPIONX LLC 2022-09-22 US claimed
WO-2021035207-A1 COMPOSITIONS FOR ENHANCED OIL RECOVERY ECOLAB USA INC. (US) 2021-02-25 WO claimed
US-12215275-B2 Compositions for enhanced oil recovery CHAMPIONX LLC 2025-02-04 US disclosed
US-12215275-B2 Compositions for enhanced oil recovery CHAMPIONX LLC 2025-02-04 US disclosed
CN-114181091-B Synthesis process of adamantane triphenylamine 维思普新材料(苏州)有限公司 2024-06-14 CN disclosed
US-20220298408-A1 COMPOSITIONS FOR ENHANCED OIL RECOVERY CHAMPIONX LLC 2022-09-22 US disclosed
US-20220298408-A1 COMPOSITIONS FOR ENHANCED OIL RECOVERY CHAMPIONX LLC 2022-09-22 US disclosed
WO-2021035207-A1 COMPOSITIONS FOR ENHANCED OIL RECOVERY ECOLAB USA INC. (US) 2021-02-25 WO disclosed
WO-2021035207-A1 COMPOSITIONS FOR ENHANCED OIL RECOVERY ECOLAB USA INC. (US) 2021-02-25 WO disclosed
CN-110407823-A Organic Light Emitting Diode material UNIVERSAL DISPLAY CORP 2019-11-05 CN disclosed
CN-104292220-B Organic Light Emitting Diode material 环球展览公司 2019-08-23 CN disclosed
CN-104292220-A Organic light emitting diode material UNIVERSAL DISPLAY CORP 2015-01-21 CN disclosed
US-8420354-B2 Methods to manufacture 1,3-dioxolane nucleosides EMORY UNIVERSITY (US) 2013-04-16 US disclosed
US-20110130559-A1 Methods to Manufacture 1,3-Dioxolane Nucleosides GILEAD SCIENCES, INC. (US) 2011-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110130559-A1 Methods to Manufacture 1,3-Dioxolane Nucleosides DCTD, AMPD1, DAD1 LMNA 266/4885TSHR 3705/4885ALOX12 620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.